Table 4.
Author [Ref.] | Survivors | Non-Survivors |
p Value [Survivors vs. Non-Survivors] |
Prediction of Mortality |
---|---|---|---|---|
Haem Rahimi et al. [66] | 1333.14 [385.14–3637.92] ng/mL | 1919 [880.75–12,098.9] ng/mL | 0.006 | Cut-off 4639 ng/mL AUC 0.63 |
Eichhorn et al. [67] | 0.09 [0.05; 0.11] AU | 0.11 [0.05; 0.2] AU | NS | NR |
Rai et al. [68] | 185.0 [68.0–1721.0] pg/µL | 345.0 [65.0–1584.2] pg/µL | 0.004 | Cut-off 215.0 [pg/μL] AUC: 0.68 [95% CI 0.56–0.80] Odds ratio 3.42 [1.35–8.68] |
Morimont et al. [69] | 785.2 [173.4–3076.1] ng/mL | 901.6 [402.7–16,032.5] ng/mL | 0.0664 | NR |
Duplessis et al. [73] | 3.2 ± 9.1 µg/mL | 5.0 ± 4.9 µg/mL | 0.007 | T0: AUC: 0.75 T24: AUC: 0.67 |
Kaufman et al. [74] | NR | NR | NR | Yes, Wald = 5.31 |
Raffray et al. [76] | 9.2 AU | 71.8 AU | p < 0.0001 | NR [available from figure] |
Miki et al. [77] | NR | NR | NS | Day 7 AUC: 0.57 |
Huson et al. [78] | 60 [25–135] AU/mL | 333 [298–456] AU/mL | 0.0002 | NR |
de Jong et al. [79] | 33.6 ± 4 AU/mL | 192.3 ± 5 AU/mL | 0.001 | NR |
Zeerleder et al. [80] | 583 (47–2329) AU/mL | 2244 [610–8638] AU/mL | 0.0061 | NR |
Chen et al. [81] | 1.97 AU | 2.58 AU | 0.06 | NR |
Zeerleder et al. [83] | 276 [35–1947] AU/mL | 628 [35–1979] AU/mL | 0.333 | NR |
AUC: area under the receiver operating characteristic curve; AU: artificial unit; NR: not reported; and NS: not significant.